Correspondence 0001193125-26-029443 from Aptevo Therapeutics Inc. (APVO)
Aptevo Therapeutics Inc.
Date: Jan. 29, 2026 · CIK: 0001671584 · Accession: 0001193125-26-029443
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-293010
Letter
January 29, 2026 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attention: Lauren S. Hamill Re: Aptevo Therapeutics Inc. Registration Statement on Form S-1 Filed January 28, 2026 File No. 333-293010 Dear Ms. Hamill: In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-1 (File No. 333-293010) of Aptevo Therapeutics Inc. (the “Registration Statement”). We respectfully request that the Registration Statement become effective as of 4:30 p.m., Eastern Time, on January 30, 2026, or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please confirm that event with our counsel, Paul Hastings LLP, by calling Sean M. Donahue at (202) 551-1704. Very truly yours, Aptevo Therapeutics Inc. By: /s/ Marvin L. White Marvin L. White President and Chief Executive Officer
CC: SoYoung Kwon, Aptevo Therapeutics Inc. Daphne Taylor, Aptevo Therapeutics Inc. Sean M. Donahue, Paul Hastings LLP
Show Raw Text
CORRESP 1 filename1.htm CORRESP January 29, 2026 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attention: Lauren S. Hamill Re: Aptevo Therapeutics Inc. Registration Statement on Form S-1 Filed January 28, 2026 File No. 333-293010 Dear Ms. Hamill: In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-1 (File No. 333-293010) of Aptevo Therapeutics Inc. (the “Registration Statement”). We respectfully request that the Registration Statement become effective as of 4:30 p.m., Eastern Time, on January 30, 2026, or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please confirm that event with our counsel, Paul Hastings LLP, by calling Sean M. Donahue at (202) 551-1704. Very truly yours, Aptevo Therapeutics Inc. By: /s/ Marvin L. White Marvin L. White President and Chief Executive Officer CC: SoYoung Kwon, Aptevo Therapeutics Inc. Daphne Taylor, Aptevo Therapeutics Inc. Sean M. Donahue, Paul Hastings LLP